Seller record · Telehealth service

SurpassMD

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The medication pages, footer and terms refer only to a licensed U.S. pharmacy and to independent licensed compounding pharmacies. 1 more criterion also fails; see the table below.

At a glance

SurpassMDTelehealth service

6/8criteria passed

Price: Compounded semaglutide from $114 a month on a 12-month supply as an introductory price, then a standard renewal rate of $143
Sells: compounded semaglutide, compounded tirzepatide, oral semaglutide
FDA letters: None on file

Visit SurpassMD See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth brand of a Delaware company selling compounded semaglutide and tirzepatide injections and oral semaglutide by subscription, with care from an independent professional medical corporation and medication from licensed compounding pharmacies. Prices are printed per supply term, as an introductory first-subscription price beside a standard renewal rate.

Operating entity Life Vitality LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	SurpassMD's website; SurpassMD's terms
S2	Prescription gating	PASS	SurpassMD's website; SurpassMD's refund policy
S3	Pharmacy identification	FAIL	SurpassMD's semaglutide product page; SurpassMD's terms; SurpassMD's website
S4	Compounding disclosure	PASS	SurpassMD's semaglutide product page; SurpassMD's website; SurpassMD's safety and rights page
S5	Analytical documentation	FAIL	SurpassMD's semaglutide product page; SurpassMD's terms; SurpassMD's safety and rights page
S6	Business address	PASS	SurpassMD's website; SurpassMD's about page; SurpassMD's terms
S7	Price disclosure	PASS	SurpassMD's semaglutide product page; SurpassMD's tirzepatide product page; SurpassMD's oral semaglutide product page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSAn independent licensed provider reviews each online assessment and decides whether treatment is appropriate, and the terms say care comes from an independent professional medical corporation whose identity is given to patients before treatment. No prescriber is named on the site.Source: SurpassMD's website; SurpassMD's terms.

S2PASSThe steps are a quiz on goals, health history and weight, then a provider's review, then shipping if approved. The cancellation policy says the first month is charged when the intake form is completed and refunded in full if the provider disqualifies the patient, so payment follows the medical questions and comes before the review.Source: SurpassMD's website; SurpassMD's refund policy.

S3FAILNo filling pharmacy is named. The medication pages, footer and terms refer only to a licensed U.S. pharmacy and to independent licensed compounding pharmacies.Source: SurpassMD's semaglutide product page; SurpassMD's terms; SurpassMD's website.

S4PASSThe medication pages call the injections compounded, the footer on every page states that compounded medications are not FDA-approved or reviewed for safety, effectiveness or quality, and the safety page repeats that compounded medications are not FDA-approved.Source: SurpassMD's semaglutide product page; SurpassMD's website; SurpassMD's safety and rights page.

S5FAILNo certificate of analysis or lot document is published on the medication pages, in the terms or on the safety page.Source: SurpassMD's semaglutide product page; SurpassMD's terms; SurpassMD's safety and rights page.

S6PASSLife Vitality LLC, doing business as SurpassMD, at 16192 Coastal Highway, Lewes, DE 19958, printed in the footer of every page. The about page says the brand is operated from Lewes, Delaware, and the terms name Delaware law.Source: SurpassMD's website; SurpassMD's about page; SurpassMD's terms.

S7PASSCompounded semaglutide carries an introductory price for the first subscription with a discount code, then a standard renewal rate: $175, then $219 a month on a 30-day supply, $156, then $195 on a 3-month supply, $144, then $180 on a 6-month supply, and $114, then $143 on a 12-month supply. Compounded tirzepatide costs $247, then $309, $232, then $299, $220, then $275, and $177, then $222 on the same terms. Oral semaglutide carries an introductory $183 a month on a one-month plan, and no later price is printed. Provider review, medication and shipping are included, with no membership fee.Source: SurpassMD's semaglutide product page; SurpassMD's tirzepatide product page; SurpassMD's oral semaglutide product page.

S8PASSNo FDA warning letter names SurpassMD or Life Vitality LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, oral semaglutide.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Visit SurpassMD

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.